In the first randomised controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...
Ivanti, a global enterprise IT and security software company, released Ivanti Connect Secure (ICS) version 25.X, marking a pivotal moment in the company's journey to redefine VPN security. The new ICS ...
News-Medical.Net on MSN
2-in-1 budesonide-formoterol inhaler reduces children's asthma attacks by 45%
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated.
News-Medical.Net on MSN
Radiomics significantly outperforms clinical models for predicting NPC treatment outcome
Nasopharyngeal carcinoma (NPC) is a highly aggressive malignancy, with most patients presenting at locally advanced stages. While immune checkpoint inhibitors, such as PD-1 blockade, have reshaped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results